ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $11,000 | -68.6% | 300 | -76.9% | 0.01% | -66.7% |
Q2 2019 | $35,000 | 0.0% | 1,300 | 0.0% | 0.03% | 0.0% |
Q1 2019 | $35,000 | +66.7% | 1,300 | 0.0% | 0.03% | +68.8% |
Q4 2018 | $21,000 | -22.2% | 1,300 | 0.0% | 0.02% | -11.1% |
Q3 2018 | $27,000 | +350.0% | 1,300 | +225.0% | 0.02% | +350.0% |
Q2 2018 | $6,000 | -86.4% | 400 | -79.5% | 0.00% | -76.5% |
Q1 2018 | $44,000 | -13.7% | 1,950 | +15.1% | 0.02% | +6.2% |
Q4 2017 | $51,000 | -3.8% | 1,694 | +20.1% | 0.02% | -5.9% |
Q3 2017 | $53,000 | +26.2% | 1,411 | -6.6% | 0.02% | +13.3% |
Q2 2017 | $42,000 | +20.0% | 1,511 | +50.3% | 0.02% | +7.1% |
Q1 2017 | $35,000 | +40.0% | 1,005 | +17.5% | 0.01% | +55.6% |
Q4 2016 | $25,000 | +78.6% | 855 | +87.9% | 0.01% | +80.0% |
Q3 2016 | $14,000 | +40.0% | 455 | +51.2% | 0.01% | 0.0% |
Q2 2016 | $10,000 | +25.0% | 301 | +0.3% | 0.01% | +66.7% |
Q1 2016 | $8,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |